Dr. Ssnegdha Sharma

Dynamic educator and clinician with a proven track record at Academically, specializing in curriculum development and faculty mentorship. Expert in data analysis and educational technology. I have successfully enhanced student engagement and learning outcomes. Committed to fostering academic excellence and improving patient care through innovative teaching strategies and collaborative practices.

• Dean from SGT University, info@sgtuniversity.org, 0124-2278183
• Dr. Clarence J. Samuel from Christian Medical College, cmclspm@gmail.com, +91-9915-661-554
• Dr. Ana-Maria Zagrean from UMF Carol Davila, azagrean@umf.ro, +40-2131-208-80
• Mr. Amichay H. Gross from E-Motion Medical Ltd, ahg@emotionmed.com
• Principal Gorakshnath Medical College and Hospital

• Poster Presentation at IAPSM Conference, Shimla, Himachal Pradesh, India, 03/19, Ayushman Bharat and Ludhiana Siums: A study to assess utilization of social security schemes for maternal and child health care.
• Poster presentation at The Conference of National Neuroscience Society of Romania, Bucharest, Romania, 10/14, The Impact of Glucose Concentration on Cerebellar Granule Cell Culture vulnerability to Ethanol and Oxygen Glucose deprivation exposure.

• Study Physician, Ludhiana, Punjab, India, 07/18, 07/21, Phase 2/3, A multi-center double-blind, randomized, placebo-controlled study to evaluate the efficacy and safety of vpm1002 in the prevention of tuberculosis (tb) recurrence in pulmonary tb patients after successful tb treatment.
• Study Physician, Ludhiana, Punjab, India, 07/19, 07/21, Phase 4, Randomized, Controlled Study of the Safety and Immunogenicity of Rabishield+Rabivax-S Post-Exposure Prophylaxis regimen in Patients with Potential Rabies Exposure.
• Study Physician, Ludhiana, Punjab, India, 07/20, 07/21, Phase 2/3, Observer-blind, randomized, controlled study to determine the safety and immunogenicity of covovax (sars-cov-2 recombinant spike protein nanoparticle vaccine (sars-cov-2 rs) with matrix-m1 adjuvant) in Indian adults.